Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction - report from ACC 2026

Professor Joo-Yong Hahn presents critical insights on the discontinuation of beta-blocker therapy in stabilized patients following an acute myocardial infarction, discussing the clinical implications and trial findings at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:discontinuation-b-blocker-therapy-stabilized-patients-after-acute-myocardial-infarction